{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:43:30Z","timestamp":1740185010883,"version":"3.37.3"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die COVID-19-Pandemie stellt das weltweite Gesundheitssystem seit 2020 vor einzigartige Herausforderungen. Faszinierend und v.\u00a0a. von besonderer gesundheitspolitischer Bedeutung ist es, dass es kaum 1\u00a0Jahr nach den ersten Berichten \u00fcber COVID-19-Infektionen mehreren Forschungsgruppen gelungen ist, Impfstoffe gegen das Coronavirus zu entwickeln. Derzeit sind 3\u00a0Klassen von Impfstoffen verf\u00fcgbar (mRNA-Impfstoffe, Vektorimpfstoffe und Impfstoffe, die das gesamte inaktivierte Virus enthalten). Wir berichten \u00fcber eine Patientin, die kurz nach der ersten Gabe des Coronaimpfstoffes von AstraZeneca\/Oxford (ChAdOx1) r\u00f6tliche, teilweise urtikarielle Hautver\u00e4nderungen am rechten Arm und der rechten Flanke entwickelte. Die L\u00e4sionen waren fl\u00fcchtig, rezidivierten allerdings in loco und anderen Lokalisationen \u00fcber einige Tage. Das klinische Bild war ungew\u00f6hnlich. Eine Unterscheidung zwischen einer \u2013\u00a0f\u00fcr uns am ehesten wahrscheinlichen\u00a0\u2013 Impfstoff-getriggerten akuten Urtikaria und einem urtikariellen Exanthem war uns nicht sicher m\u00f6glich.<\/jats:p>","DOI":"10.1007\/s00105-023-05160-3","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T16:01:51Z","timestamp":1685116911000},"page":"614-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rezidivierende Livedo-artige Hautver\u00e4nderungen nach einer Vektor-basierten COVID-19-Impfung","Recurrent livedo-like skin lesions following a\u00a0vector-based COVID-19 vaccine"],"prefix":"10.1007","volume":"74","author":[{"given":"Teresa","family":"Kr\u00e4nke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urban","family":"Cerpes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Legat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Arbab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birger","family":"Kr\u00e4nke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"issue":"3","key":"5160_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.clindermatol.2021.04.001","volume":"39","author":"G Bogdanov","year":"2021","unstructured":"Bogdanov\u00a0G, Bogdanov\u00a0I, Kazandjieva\u00a0J, Tsankov\u00a0N (2021) Cutaneous adverse effects of the available COVID-19 vaccines. Clin Dermatol 39(3):523\u2013531","journal-title":"Clin Dermatol"},{"key":"5160_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15360","author":"N Namazi","year":"2022","unstructured":"Namazi\u00a0N, Diab\u00a0R, Mardani\u00a0G et al (2022) Figurate purpuric eruption post-Covid-19 vaccination. Dermatol Ther. https:\/\/doi.org\/10.1111\/dth.15360","journal-title":"Dermatol Ther"},{"issue":"1","key":"5160_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bjd.20639","volume":"186","author":"A Catal\u00e1","year":"2022","unstructured":"Catal\u00e1\u00a0A, Munoz-Santos\u00a0C, Galv\u00e1n-Casas\u00a0C et al (2022) Cutaneous reactions after SARS-CoV\u20112 vaccination: a cross-sectional Spanish nationwide study of 405\u00a0cases. Br J Dermatol 186(1):142\u2013152","journal-title":"Br J Dermatol"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05160-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T15:02:57Z","timestamp":1690210977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05160-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":3,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["5160"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05160-3","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"type":"print","value":"2731-7005"},{"type":"electronic","value":"2731-7013"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"19 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Kr\u00e4nke, U.\u00a0Cerpes, F.\u00a0Legat, E.\u00a0Arbab und B.\u00a0Kr\u00e4nke geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}